Cancer
Mathematical model driven evolutionary therapy dosing exploiting cancer cell plasticity
Cancer poses significant challenges due to the development of resistance and the likelihood of relapse. Resistance may arise from permanent...
Study assesses cancer-related care at US hospitals predominantly serving minority populations compared with non-minority serving hospitals
It’s important to ensure that care provided at US hospitals that predominantly serve Black and Hispanic populations is as high-quality...
First in-human investigator-initiated clinical trial to launch for refractory prostate cancer patients: Novel alpha therapy targets prostate-specific membrane antigen
Osaka, Japan - A research team at Osaka University will start an investigator-initiated clinical trial for refractory prostate cancer patients...
PKMYT1, a potential ‘Achilles heel’ of treatment resistant ER+ breast cancers with the poorest prognosis
Up to 80% of breast cancer deaths occur in patients with tumors that express estrogen receptor-alpha. Although these estrogen receptor-positive...
PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors (PARs)
“We have identified binding motifs within the C-tails of PAR1,2&4, indispensable for cancer growth and development.”Credit: 2024 Nag et al....
Possible association between tattoos and lymphoma revealed
A new study from Lund University in Sweden suggests that tattoos could be a risk factor for cancer in the...
MSK Research Highlights, May 24, 2024
New research from Memorial Sloan Kettering Cancer Center (MSK) investigates a promising approach against diabetic retinopathy and finds patients with...
ASCO: Large precision oncology study identifies differences in prostate cancer genomics among a racially and ethnically diverse cohort of U.S. veterans
FINDINGS FINDINGS A new study led by a UCLA-VA collaborative team looking at the landscape of genomic alterations in more than 5,000 veterans...
ASCO: Combination therapy significantly improves outcomes for patients with metastatic colorectal cancer
FINDINGS FINDINGS A study led by UCLA Health Jonsson Comprehensive Cancer Center researchers found that using a combination of experimental immunotherapy drugs with chemotherapy significantly...
First made-in-Singapore antibody-drug conjugate EBC-129 progresses to phase 1B dose expansion
The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development, is pleased to announce that the...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!